Senegal produces local sickle cell treatment
Senegal has emerged as the first African country to locally manufacture a generic treatment for sickle cell disease, with the production of DREPAF, a hydroxyurea-based medicine, by Senegalese pharmaceutical company Teranga Pharma. The drug is being produced in partnership with Drep.Afrique as part of efforts to improve access to an established treatment for one of…
